Equities

Health Empire Corporation PCL

Health Empire Corporation PCL

Actions
  • Price (THB)0.31
  • Today's Change-0.04 / -11.43%
  • Shares traded7.77m
  • 1 Year change-88.08%
  • Beta--
Data delayed at least 15 minutes, as of Nov 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Health Empire Corporation Public Company Limited is a Thailand-based company engaged in health and medical technology. The Company’s segments include selling herbal program and products and service program network. The Company’s businesses include Mediwell Company Limited, Herbal Technology Company Limited, HealthUp Group Company Limited, DN CENTER 2019 CO.,LTD., and Xserve Fulfillment Company Limited. Mediwell Company Limited is engaged in the business of developing integrated health products and services. Herbal Technology Company Limited is engaged in the business of manufacturing and distributing traditional medicine products. HealthUp Group Company Limited is involved in the business of selling pharmaceutical products. DN CENTER 2019 CO.,LTD. is engaged in the retail and wholesale of medicines, medicines, medical supplies, medical equipment. Xserve Fulfillment Company Limited is involved in transportation and storage services.

  • Revenue in THB (TTM)21.95m
  • Net income in THB-498.22m
  • Incorporated1990
  • Employees358.00
  • Location
    Health Empire Corporation PCL20 Praditmanutham RoadPubpla, WangthonglangBANGKOK 10240ThailandTHA
  • Phone+66 25145000
  • Fax+66 25145000
  • Websitehttps://www.hempcorp.co.th/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Health Empire Corporation PCL21.95m-498.22m131.03m358.00--0.2722--5.97-1.30-1.300.05721.140.0293.070.4379---66.16-28.88-71.23-32.8340.3029.72-2,280.86-210.713.85--0.057---82.50-39.6342.16---2.43--
TVD Holdings PCL1.30bn-160.00m332.95m1.50k--0.5262--0.2566-0.093-0.0930.74450.3610.801213.959.69---10.58-13.80-20.60-26.3648.0041.24-13.21-7.250.2765-3.070.3606---16.12-14.89-20.18---16.40--
OCC PCL900.43m12.66m537.00m773.0042.410.52118.340.59640.2110.21115.0117.180.72421.948.451,164,846.000.97730.04361.100.049649.2945.481.350.06132.39--0.0141493.146.41-6.4177.63---10.67-38.57
Autocorp Holding PCL1.57bn19.39m570.00m430.0028.470.80847.320.36360.03340.03342.671.181.239.1745.363,645,335.001.532.212.203.8414.799.391.251.470.52942.740.370648.322.34-5.439.47-8.79-27.53--
Data as of Nov 20 2024. Currency figures normalised to Health Empire Corporation PCL's reporting currency: Thai Baht THB
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.